Radiation therapist

Varian Ranked Highest in Survey of US Radiation Oncology Professionals

Retrieved on: 
Tuesday, January 19, 2021
Medical physics, Medicine, Radiobiology, Nuclear physics, Radioactivity, Physical sciences, External beam radiotherapy, Radiation therapy, Radiation therapist, Proton therapy

The IMV ServiceTrak Radiation Oncology Systems report is a survey of U.S. hospital oncology professionals who perform therapeutic radiation oncology treatments using external beam radiation therapy systems.

Key Points: 
  • The IMV ServiceTrak Radiation Oncology Systems report is a survey of U.S. hospital oncology professionals who perform therapeutic radiation oncology treatments using external beam radiation therapy systems.
  • The survey results from interviews with 345 unique radiation therapy sites representing 533 systems.
  • Respondents participated in online data collection between April 28, 2020 August 31, 2020 and during phone interviews from July 14, 2020 September 1, 2020.
  • At Varian, we envision a world without fear of cancer.

Gerry Vantellingen Joins Akesis as President

Retrieved on: 
Thursday, October 22, 2020
Radiation therapy, Radioactivity, Radiobiology, Radiation therapist, Oncology, Physical sciences, Physics, Natural sciences

CONCORD, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Gerry Vantellingen has joined Akesis as President, the company announced today.

Key Points: 
  • CONCORD, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Gerry Vantellingen has joined Akesis as President, the company announced today.
  • Vantellingen has held a variety of global leadership positions with several leading radiation oncology solutions providers for more than 30 years.
  • Vantellingen started his career as a Radiation Therapist and has progressed his career through a variety of multinational companies.
  • I am delighted to join the outstanding team at Akesis and to support the inventive approach that is simplifying SRS and expanding radiotherapy options, Vantellingen said.

United States Radiation Oncology Market Size, Share & Trends Analysis Report, 2020-2027 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 15, 2020
Radiology, Health, Oncology, Medical physics, Radiobiology, Medicine, Radiation therapy, Radioactivity, Physical sciences, Nuclear physics, Oncology, Proton therapy, Radiation therapist

Radiation Oncology Market Size, Share & Trends Analysis Report by Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), by Technology, by Application, and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • Radiation Oncology Market Size, Share & Trends Analysis Report by Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), by Technology, by Application, and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.
  • The U.S. radiation oncology market size is expected to reach USD 3.9 billion by 2027, expanding at a CAGR of 5.0%
    Increasing the prevalence of cancer and technological advancements in radiation oncology are some of the key factors responsible for market growth.
  • Advancements in technologies are anticipated to reduce the adverse effects of radiotherapy and improve its overall quality.
  • Advancements in radiation oncology can enable the delivery of a high dose to a target area without any damage to adjacent healthy tissues.

Legion Healthcare Partners Collaborates with Industry Experts to Provide Proton Therapy Dosimetry Education

Retrieved on: 
Tuesday, June 30, 2020
Medical physics, Academic disciplines, Physical sciences, Health sciences, Radiobiology, Proton, Proton therapy, Radiation therapy, Therapy, PROTON Holdings, Dosimetry, Radiation therapist

Legion Healthcare Partners, working with an international group of dosimetry and physics professionals, has developed the first of its kind structured education program for proton dosimetry.

Key Points: 
  • Legion Healthcare Partners, working with an international group of dosimetry and physics professionals, has developed the first of its kind structured education program for proton dosimetry.
  • The Legion proton therapy education and training program offers 16 CE credit hours and those who enroll in the program can be assured of receiving the highest quality training from prominent proton therapy experts.
  • The program Legion Healthcare Partners and faculty advisors have developed will allow dosimetrists to get their training online from experts in proton therapy," said Cara Sullivan, AAMD President.
  • Legion Healthcare Partners is a group of healthcare executives, clinical advisors and domain experts that provide financing, development, ownership, management services and certified educational programs for radiation oncology with an emphasis on proton therapy.

Florida Cancer Specialists & Research Institute Provides Hypofractionation Radiation Therapy

Retrieved on: 
Wednesday, May 6, 2020
Health, Medicine, Medical physics, Oncology, Radiation therapy, Texas Oncology, Radiation therapist

Fort Myers, Fla., May 06, 2020 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute (FCS) offers an advanced radiation therapy option for several types of cancers, which can lead to faster and shorter rounds of radiation therapy for patients.

Key Points: 
  • Fort Myers, Fla., May 06, 2020 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute (FCS) offers an advanced radiation therapy option for several types of cancers, which can lead to faster and shorter rounds of radiation therapy for patients.
  • Hypofractionated radiation is a treatment technique where the total dose of radiation is delivered in fewer treatment sessions and results in large fractional doses being administered over a shorter time period compared to standard radiation therapy.
  • About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
    Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida.
  • In the past four years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.

Northwestern Medicine HealthCare to Implement AI Decision Support Platform From Siris Medical to Ensure High Quality Treatment While Streamlining Prior-Authorization Workflow

Retrieved on: 
Wednesday, April 15, 2020
Research, Technology, Hospitals, Clinical trials, Software, Internet, Radiology, Health, Science, Oncology, Radiation therapy, Radioactivity, Radiobiology, Oncology, Health, Branches of biology, Physical sciences, Radiation therapist

NM will implement Siriss InsightRTTM software as the primary treatment decision-support tool for the treatment of cancer patients.

Key Points: 
  • NM will implement Siriss InsightRTTM software as the primary treatment decision-support tool for the treatment of cancer patients.
  • According to a survey performed by the American Society of Therapeutic Radiation Oncology, insurance authorization can result in unnecessary treatment delays and impact patient care.
  • Colin Carpenter PhD, President and CEO of Siris Medical adds: We are excited to support NM in their innovative approach to ensure every patient receives the best cancer treatment.
  • Siris Medical empowers clinicians to achieve efficient high-quality cancer radiation treatment decisions through its artificial intelligence platform, InsightRT, the first commercial decision-support system in radiation oncology.

Dr. Larry Kestin, 21st Century Oncology's Medical Director, Michigan Region, Named A Fellow of the American Society for Radiation and Oncology (ASTRO)

Retrieved on: 
Wednesday, October 2, 2019
Health, American Society for Radiation Oncology, Radiation therapist, Radiation therapy, Medicine, Oncology, Texas Oncology, Beatriz Amendola

FARMINGTON HILLS, Mich., Oct. 2, 2019 /PRNewswire/ --The American Society for Radiation and Oncology (ASTRO), the world's largest society for radiation oncology professionals, recently voted to confer upon 21st Century Oncology Medical Director, Michigan Region, Dr. Larry Kestin the designation of American Society for Radiation Oncology Fellow (FASTRO), which recognizes physicians who have made significant contributions to radiation oncology.

Key Points: 
  • FARMINGTON HILLS, Mich., Oct. 2, 2019 /PRNewswire/ --The American Society for Radiation and Oncology (ASTRO), the world's largest society for radiation oncology professionals, recently voted to confer upon 21st Century Oncology Medical Director, Michigan Region, Dr. Larry Kestin the designation of American Society for Radiation Oncology Fellow (FASTRO), which recognizes physicians who have made significant contributions to radiation oncology.
  • In addition to serving as Medical Director, Dr. Kestin treats patients at MHP Radiation Oncology Institute, a practice of 21st Century Oncology, the nation's largest integrated cancer care network.
  • The American Society for Radiation Oncology (ASTRO) is the world's largest radiation oncology society, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies.
  • ASTRO publishes three medical journals, International Journal of Radiation Oncology Biology Physics , Practical Radiation Oncology and Advances in Radiation Oncology ; developed and maintains an extensive patient website, RT Answers ; and created the nonprofit foundation Radiation Oncology Institute .

Varian Ranked Highest in Survey of US Radiation Oncology Professionals

Retrieved on: 
Monday, September 16, 2019
Medical physics, Radiation therapy, Radioactivity, Radiobiology, Medicine, Health, Branches of biology, Radiation therapist, Proton therapy

The IMV ServiceTrak Radiation Oncology Systems report is a survey of U.S. hospital oncology professionals who perform therapeutic radiation oncology treatments using external beam radiation therapy systems.

Key Points: 
  • The IMV ServiceTrak Radiation Oncology Systems report is a survey of U.S. hospital oncology professionals who perform therapeutic radiation oncology treatments using external beam radiation therapy systems.
  • The survey results from interviews with 334 unique radiation therapy sites representing 511 systems.
  • Interviews were conducted by phone from May to July, 2019.
  • At Varian, we envision a world without fear of cancer.

Clinical trial results and radiation oncology research to be featured at ASTRO's Annual Meeting in San Antonio

Retrieved on: 
Monday, October 1, 2018
American Society for Radiation Oncology, Radiation therapy, Radiation therapist, Health, Astro, Physics

Researchers will present their findings in three news briefings held October 21 through 23 in room 225-D of the Henry B. Gonzalez Convention Center in San Antonio and via live webcast.

Key Points: 
  • Researchers will present their findings in three news briefings held October 21 through 23 in room 225-D of the Henry B. Gonzalez Convention Center in San Antonio and via live webcast.
  • Reporters can register to cover the meeting and news briefings at www.astro.org/ampress .
  • More information about the meeting is available at the ASTRO Annual Meeting webpage .
  • The American Society for Radiation Oncology (ASTRO) is the world's largest radiation oncology society, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies.